Sex-gender differences in diabetes vascular complications and treatment

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 179-196

  Franconi, Flavia ^a,b   Campesi, Ilaria ^a,b   Occhioni, Stefano ^a,b   Tonolo, Giancarlo ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Laboratory of Sex Gender Medicine   (Italy)

^c SC Ospedaliera Diabetologia Aziendale e Malattie Metaboliche ASL   (Italy)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Diabetic complications; Risk factors; Sex gender differences; Therapy

Indexed keywords

ACARBOSE; ALPHA 2A ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTAMATE DECARBOXYLASE; INSULIN; INTERLEUKIN 6; IRBESARTAN; MESSENGER RNA; METFORMIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGING; ALZHEIMER DISEASE; ANDROGEN DEFICIENCY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEPRESSION; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; ENERGY METABOLISM; ESTROGEN DEFICIENCY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEALTH CARE COST; HEALTH STATUS; HEREDITY; HUMAN; HYPOGONADISM; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; METABOLIC SYNDROME X; MICROANGIOPATHY; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PREVALENCE; PSYCHOLOGICAL ASPECT; QT PROLONGATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL STATUS; WEIGHT CHANGE;

AGING; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; SEX FACTORS;

EID: 84861134085     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012800493512     Document Type: Article

References (256)

1. Marino, M.; Masella, R.; Bulzomi, P.; Campesi, I.; Malorni, W. and Franconi, F. (2011) Nutrition and human health from a sexgender perspective. Mol. Aspects Med., 32(1), 1-70.
2. Franconi, F.; Brunelleschi, S.; Steardo, L. and Cuomo, V. (2007) Gender differences in drug responses. Pharmacol. Res., 55(2), 81-95.
3. Blair, M. L. (2007) Sex-based differences in physiology: what should we teach in the medical curriculum? Adv. Physiol. Educ., 31(1), 23-25.
4. Legato, M. J. and Bilezikian, J. P. Principles of gender-specific medicine. Boston: Elsevier Academic Press: Amsterdam, 2004; p. 1245.
5. Liu, S. and Mauvais-Jarvis, F. (2010) Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology, 151(3), 859-864.
6. Giuffrida, F. M. and Reis, A. F. (2005) Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes. Metab., 7(4), 318-326.
7. Eaton, W. W.; Rose, N. R.; Kalaydjian, A.; Pedersen, M. G. and Mortensen, P. B. (2007) Epidemiology of autoimmune diseases in Denmark. J. Autoimmun., 29(1), 1-9.
8. Lindholm, E.; Hallengren, B. and Agardh, C. D. (2004) Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab. Res. Rev., 20(2), 158-164.
9. Buchanan, T. A. and Xiang, A. H. (2005) Gestational diabetes mellitus. J. Clin. Invest., 115(3), 485-491.
10. Wild, S.; Roglic, G.; Green, A.; Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047-1053.
11. Szalat, A. and Raz, I. (2008) Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes. Metab., 10(12), 1135-1156.
12. World Health Organization. The challenge of obesity in the WHO European Region and the strategies for response: summary; Regional Office for Europe: 2007.
13. Blouin, K.; Boivin, A. and Tchernof, A. (2008) Androgens and body fat distribution. J. Steroid. Biochem. Mol. Biol., 108(3-5), 272-280.
14. Seghieri, G.; Tesi, F.; Anichini, R.; De Bellis, A.; Fabbri, G.; Malagoli, R. and Franconi, F. (2008) Gender modulates the relationship between body weight and plasma glucose in overweight or obese subjects. Diabetes Res. Clin. Pract., 80(1), 134-138.
15. Berrahmoune, H.; Herbeth, B.; Samara, A.; Marteau, J. B.; Siest, G. and Visvikis-Siest, S. (2008) Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int. J. Obes. (Lond)., 32(8), 1279-1288.
16. Eckel, R. H.; Grundy, S. M. and Zimmet, P. Z. (2005) The metabolic syndrome. Lancet, 365(9468), 1415-1428.
17. Pilote, L.; Dasgupta, K.; Guru, V.; Humphries, K. H.; McGrath, J.; Norris, C.; Rabi, D.; Tremblay, J.; Alamian, A.; Barnett, T.; Cox, J.; Ghali, W. A.; Grace, S.; Hamet, P.; Ho, T.; Kirkland, S.; Lambert, M.; Libersan, D.; O'Loughlin, J.; Paradis, G.; Petrovich, M. and Tagalakis, V. (2007) A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ, 176(6), S1-44.
18. International Diabetes Federation. Prevalence estimates of diabetes mellitus (DM)-European Region. 3rd ed.; Brussels, 2006.
19. Williams, J. W.; Zimmet, P. Z.; Shaw, J. E.; de Courten, M. P.; Cameron, A. J.; Chitson, P.; Tuomilehto, J. and Alberti, K. G. (2003) Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet. Med., 20(11), 915-920.
20. DECODE Study Group. (2003) Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care, 26(1), 61-69.
21. Meigs, J. B.; Nathan, D. M.; D'Agostino, R. B. Sr. and Wilson, P. W. (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care, 25(10), 1845-1850.
22. Kanaya, A. M.; Grady, D. and Barrett-Connor, E. (2002) Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch. Intern. Med., 162(15), 1737-1745.
23. Anderwald, C. H.; Krebs, M.; Promintzer-Schifferl, M.; Luger, A.; Kautzky-Willer, A. and Anderwald-Stadler, M. (2008) Glukoseresorption während des oralen Glukosetoleranztests bei Glukose-toleranten Frauen und Mannern. Wien Klin. Wochenschr., 120, 3.
24. Hanefeld, M.; Koehler, C.; Fuecker, K.; Henkel, E.; Schaper, F. and Temelkova-Kurktschiev, T. (2003) Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care, 26(3), 868-874.
25. Nuutila, P.; Knuuti, M. J.; Maki, M.; Laine, H.; Ruotsalainen, U.; Teras, M.; Haaparanta, M.; Solin, O. and Yki-Jarvinen, H. (1995) Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes, 44 (1), 31-36.
26. Clausen, J. O.; Borch-Johnsen, K.; Ibsen, H.; Bergman, R. N.; Hougaard, P.; Winther, K. and Pedersen, O. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J. Clin. Invest., 98(5), 1195-1209.
27. Wynn, J. W.; Doar, J. W. and Mills, G. L. (1966) Some effects of oral contraceptives on serum-lipid and lipoprotein levels. Lancet, 2(7466), 720-723.
28. Ehtisham, S.; Hattersley, A. T.; Dunger, D. B. and Barrett, T. G. (2004) First UK survey of paediatric type 2 diabetes and MODY. Arch. Dis. Child, 89(6), 526-529.
29. Rosenbloom, A. L.; Joe, J. R.; Young, R. S. and Winter, W. E. (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22(2), 345-354.
30. Fagot-Campagna, A.; Pettitt, D. J.; Engelgau, M. M.; Burrows, N. R.; Geiss, L. S.; Valdez, R.; Beckles, G. L.; Saaddine, J.; Gregg, E. W.; Williamson, D. F. and Narayan, K. M. (2000) Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr., 136(5), 664-672.
31. Shields, B. M.; Knight, B.; Hopper, H.; Hill, A.; Powell, R. J.; Hattersley, A. T. and Clark, P. M. (2007) Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care, 30(10), 2661-2666.
32. Murphy, M. J.; Metcalf, B. S.; Voss, L. D.; Jeffery, A. N.; Kirkby, J.; Mallam, K. M. and Wilkin, T. J. (2004) Girls at five are intrinsically more insulin resistant than boys: The Programming Hypotheses Revisited--The EarlyBird Study (EarlyBird 6). Pediatrics, 113(1 Pt 1), 82-86.
33. Bavdekar, A.; Yajnik, C. S.; Fall, C. H.; Bapat, S.; Pandit, A. N.; Deshpande, V.; Bhave, S.; Kellingray, S. D. and Joglekar, C. (1999) Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes, 48(12), 2422-2429.
34. Young-Hyman, D.; Schlundt, D. G.; Herman, L.; De Luca, F. and Counts, D. (2001) Evaluation of the insulin resistance syndrome in 5-to 10-year-old overweight/obese African-American children. Diabetes Care, 24(8), 1359-1364.
35. Moran, A.; Jacobs, D. R. Jr.; Steinberger, J.; Hong, C. P.; Prineas, R.; Luepker, R. and Sinaiko, A. R. (1999) Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes, 48(10), 2039-2044.
36. Travers, S. H.; Jeffers, B. W.; Bloch, C. A.; Hill, J. O. and Eckel, R. H. (1995) Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J. Clin. Endocrinol. Metab., 80(1), 172-178.
37. Ehtisham, S.; Crabtree, N.; Clark, P.; Shaw, N. and Barrett, T. (2005) Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J. Clin. Endocrinol. Metab., 90(7), 3963-3969.
38. Alberti, K. G.; Zimmet, P. and Shaw, J. (2005) The metabolic syndrome--a new worldwide definition. Lancet, 366(9491), 1059-1062.
39. Regitz-Zagrosek, V.; Lehmkuhl, E. and Mahmoodzadeh, S. (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend. Med., 4 (Suppl B), S162-177.
40. Bjornholm, M. and Zierath, J. R. (2005) Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem. Soc. Trans., 33(Pt 2), 354-357.
41. Mauvais-Jarvis, F. (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol. Metab., 22(1), 24-33.
42. Dhindsa, S.; Prabhakar, S.; Sethi, M.; Bandyopadhyay, A.; Chaudhuri, A. and Dandona, P. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J. Clin. Endocrinol. Metab., 89(11), 5462-5468.
43. Mulligan, T.; Frick, M. F.; Zuraw, Q. C.; Stemhagen, A. and McWhirter, C. (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int. J. Clin. Pract., 60(7), 762-769.
44. Francomano, D.; Bruzziches, R.; Natali, M.; Aversa, A. and Spera, G. (2010) Cardiovascular effect of testosterone replacement therapy in aging male. Acta. Biomed., 81(Suppl 1), 101-106.
45. Haffner, S. M. (1996) Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm. Res., 45(3-5), 233-237.
46. Marin, P. and Arver, S. (1998) Androgens and abdominal obesity. Baillieres Clin. Endocrinol. Metab., 12(3), 441-451.
47. Basaria, S.; Coviello, A. D.; Travison, T. G.; Storer, T. W.; Farwell, W. R.; Jette, A. M.; Eder, R.; Tennstedt, S.; Ulloor, J.; Zhang, A.; Choong, K.; Lakshman, K. M.; Mazer, N. A.; Miciek, R.; Krasnoff, J.; Elmi, A.; Knapp, P. E.; Brooks, B.; Appleman, E.; Aggarwal, S.; Bhasin, G.; Hede-Brierley, L.; Bhatia, A.; Collins, L.; LeBrasseur, N.; Fiore, L. D. and Bhasin, S. (2010) Adverse events associated with testosterone administration. N. Engl. J. Med., 363(2), 109-122.
48. Meyer, I. H.; Schwartz, S. and Frost, D. M. (2008) Social patterning of stress and coping: does disadvantaged social statuses confer more stress and fewer coping resources? Soc. Sci. Med., 67(3), 368-379.
49. Robbins, J. M.; Vaccarino, V.; Zhang, H. and Kasl, S. V. (2001) Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am. J. Public Health, 91(1), 76-83.
50. Stelmach, W.; Kaczmarczyk-Chalas, K.; Bielecki, W. and Drygas, W. (2005) How education, income, control over life and life style contribute to risk factors for cardiovascular disease among adults in a post-communist country. Public Health, 119(6), 498-508.
51. Rabi, D. M.; Edwards, A. L.; Southern, D. A.; Svenson, L. W.; Sargious, P. M.; Norton, P.; Larsen, E. T. and Ghali, W. A. (2006) Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv. Res., 6, 124.
52. Tamayo, T.; Christian, H. and Rathmann, W. (2010) Impact of early psychosocial factors (childhood socioeconomic factors and adversities) on future risk of type 2 diabetes, metabolic disturbances and obesity: a systematic review. BMC Public Health, 10, 525.
53. Connolly, V.; Unwin, N.; Sherriff, P.; Bilous, R. and Kelly, W. (2000) Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. J. Epidemiol. Community Health, 54(3), 173-177.
54. World Health Organization. Prevention of diabetes mellitus; Geneva, 1994.
55. Colhoun H.; Lampe F. and W.D. Obesity In Health Survey for England 1994, P, C. H. a. P.-C., Ed. London, 1995.
56. Unwin, N.; Watson, W. and J., H. (1995) Social class differences in the prevalence of glucose intolerance. Diabetic Med., 12, s31.
57. Hales, C. N.; Barker, D. J.; Clark, P. M.; Cox, L. J.; Fall, C.; Osmond, C. and Winter, P. D. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ, 303(6809), 1019-1022.
58. Smith, M.; Hopkins, D.; Peveler, R. C.; Holt, R. I.; Woodward, M. and Ismail, K. (2008) First-v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and metaanalysis. Br. J. Psychiatry, 192(6), 406-411.
59. Chen da, C.; Zhou, M. A.; Zhou, D. H.; Xiu, M. H.; Wu, G. Y.; Kosten, T. R. and Zhang, X. Y. (2011) Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics. Psychiatry Res., 186(2-3), 451-453.
60. Anderson, R. J.; Freedland, K. E.; Clouse, R. E. and Lustman, P. J. (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 24(6), 1069-1078.
61. Gavard, J. A.; Lustman, P. J. and Clouse, R. E. (1993) Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care, 16(8), 1167-1178.
62. Nichols, G. A. and Brown, J. B. (2003) Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care, 26(3), 744-749.
63. Egede, L. E. (2004) Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care, 27(7), 1751-1753.
64. Black, S. A.; Markides, K. S. and Ray, L. A. (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care, 26(10), 2822-2828.
65. Finkelstein, E. A.; Bray, J. W.; Chen, H.; Larson, M. J.; Miller, K.; Tompkins, C.; Keme, A. and Manderscheid, R. (2003) Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care, 26(2), 415-420.
66. de Groot, M.; Anderson, R.; Freedland, K. E.; Clouse, R. E. and Lustman, P. J. (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom. Med., 63(4), 619-630.
67. Ciechanowski, P. S.; Katon, W. J. and Russo, J. E. (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med., 160(21), 3278-3285.
68. Ciechanowski, P. S.; Katon, W. J.; Russo, J. E. and Hirsch, I. B. (2003) The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen. Hosp. Psychiatry, 25(4), 246-252.
69. Lin, E. H.; Katon, W.; Von Korff, M.; Rutter, C.; Simon, G. E.; Oliver, M.; Ciechanowski, P.; Ludman, E. J.; Bush, T. and Young, B. (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care, 27(9), 2154-2160.
70. Lustman, P. J.; Anderson, R. J.; Freedland, K. E.; de Groot, M.; Carney, R. M. and Clouse, R. E. (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care, 23(7), 934-942.
71. Zhang, X.; Norris, S. L.; Gregg, E. W.; Cheng, Y. J.; Beckles, G. and Kahn, H. S. (2005) Depressive symptoms and mortality among persons with and without diabetes. Am. J. Epidemiol., 161(7), 652-660.
72. Grant, J. F.; Hicks, N.; Taylor, A. W.; Chittleborough, C. R. and Phillips, P. J. (2009) Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int. J. Equity Health, 8(1), 6.
73. Takeda, S.; Sato, N.; Rakugi, H. and Morishita, R. (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol. Biosyst., 7(6), 1822-1827.
74. de la Monte, S. M. and Wands, J. R. (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol., 2(6), 1101-1113.
75. Bosco, D.; Fava, A.; Plastino, M.; Montalcini, T. and Pujia, A. (2011) Possible implications of Insulin Resistance and Glucose metabolism in Alzheimer's disease pathogenesis. J. Cell Mol. Med., 15(9), 1807-1821.
76. Sinforiani, E.; Citterio, A.; Zucchella, C.; Bono, G.; Corbetta, S.; Merlo, P. and Mauri, M. (2010) Impact of gender differences on the outcome of Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 30(2), 147-154.
77. Tonolo, G.; Ciccarese, M.; Brizzi, P.; Milia, S.; Dessole, S.; Puddu, L.; Secchi, G. and Maioli, M. (1995) Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women. Am. J. Physiol., 269 (6 Pt 1), E1101-1105.
78. Brizzi, P.; Dessole, S.; Tonolo, G.; Capobianco, G.; Milia, L.; Puddu, L. and Nardo, L. G. (2003) Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer. Reprod. Biomed. Online, 7(3), 309-312.
79. Brizzi, P.; Tonolo, G.; Esposito, F.; Puddu, L.; Dessole, S.; Maioli, M. and Milia, S. (1999) Lipoprotein metabolism during normal pregnancy. Am. J. Obstet. Gynecol., 181(2), 430-434.
80. Buchanan, T. A.; Metzger, B. E.; Freinkel, N. and Bergman, R. N. (1990) Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am. J. Obstet. Gynecol., 162(4), 1008-1014.
81. Case, A. M. and Reid, R. L. (2001) Menstrual cycle effects on common medical conditions. Compr. Ther., 27(1), 65-71.
82. Solomon, C. G.; Hu, F. B.; Dunaif, A.; Rich-Edwards, J.; Willett, W. C.; Hunter, D. J.; Colditz, G. A.; Speizer, F. E. and Manson, J. E. (2001) Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA, 286(19), 2421-2426.
83. Dunaif, A.; Segal, K. R.; Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38(9), 1165-1174.
84. Yang, J. and Holman, G. D. (2006) Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMPactivated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology, 147(6), 2728-2736.
85. van Genugten, R. E.; Utzschneider, K. M.; Tong, J.; Gerchman, F.; Zraika, S.; Udayasankar, J.; Boyko, E. J.; Fujimoto, W. Y. and Kahn, S. E. (2006) Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes, 55(12), 3529-3535.
86. Jones, M. E.; Thorburn, A. W.; Britt, K. L.; Hewitt, K. N.; Wreford, N. G.; Proietto, J.; Oz, O. K.; Leury, B. J.; Robertson, K. M.; Yao, S. and Simpson, E. R. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. USA, 97(23), 12735-12740.
87. Takeda, K.; Toda, K.; Saibara, T.; Nakagawa, M.; Saika, K.; Onishi, T.; Sugiura, T. and Shizuta, Y. (2003) Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol., 176(2), 237-246.
88. Faustini-Fustini, M.; Rochira, V. and Carani, C. (1999) Oestrogen deficiency in men: where are we today? Eur. J. Endocrinol., 140(2), 111-129.
89. Komukai, K.; Mochizuki, S. and Yoshimura, M. (2010) Gender and the renin-angiotensin-aldosterone system. Fundam. Clin. Pharmacol., 24(6), 687-698.
90. Freire, M. B.; Ji, L.; Onuma, T.; Orban, T.; Warram, J. H. and Krolewski, A. S. (1998) Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension, 31 (4), 896-899.
91. Pettersson-Fernholm, K.; Frojdo, S.; Fagerudd, J.; Thomas, M. C.; Forsblom, C.; Wessman, M. and Groop, P. H. (2006) The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type I diabetic patients. Kidney Int., 69(10), 1880-1884.
92. Shu, Y. H.; Hartiala, J.; Xiang, A. H.; Trigo, E.; Lawrence, J. M.; Allayee, H.; Buchanan, T. A.; Bottini, N. and Watanabe, R. M. (2009) Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. J. Clin. Endocrinol. Metab., 94(10), 4094-4102.
93. Yamaguchi, S.; Yamada, Y.; Matsuo, H.; Segawa, T.; Watanabe, S.; Kato, K.; Yokoi, K.; Ichihara, S.; Metoki, N.; Yoshida, H.; Satoh, K. and Nozawa, Y. (2007) Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus. Int. J. Mol. Med., 19(4), 631-637.
94. Winzer, C.; Wagner, O.; Festa, A.; Schneider, B.; Roden, M.; Bancher-Todesca, D.; Pacini, G.; Funahashi, T. and Kautzky-Willer, A. (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care, 27(7), 1721-1727.
95. Farhan, S.; Winzer, C.; Tura, A.; Quehenberger, P.; Bieglmaier, C.; Wagner, O. F.; Huber, K.; Waldhausl, W.; Pacini, G. and Kautzky-Willer, A. (2006) Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes. Eur. J. Clin. Invest., 36(5), 345-352.
96. Saltevo, J.; Kautiainen, H. and Vanhala, M. (2009) Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend. Med., 6(3), 463-470.
97. Evans, R. W. and Orchard, T. J. (1994) Oxidized lipids in insulindependent diabetes mellitus: a sex-diabetes interaction? Metabolism, 43(9), 1196-1200.
98. Legato, M. J.; Gelzer, A.; Goland, R.; Ebner, S. A.; Rajan, S.; Villagra, V. and Kosowski, M. (2006) Gender-specific care of the patient with diabetes: review and recommendations. Gend. Med., 3(2), 131-158.
99. Marra, G.; Cotroneo, P.; Pitocco, D.; Manto, A.; Di Leo, M. A.; Ruotolo, V.; Caputo, S.; Giardina, B.; Ghirlanda, G. and Santini, S. A. (2002) Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care, 25(2), 370-375.
100. Giacco, F. and Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ. Res., 107(9), 1058-1070.
101. Lista, P.; Straface, E.; Brunelleschi, S.; Franconi, F. and Malorni, W. (2011) On the Role of Autophagy in Human Diseases: a Gender Perspective. J. Cell Mol. Med., 15(7), 1443-1457
102. Malorni, W.; Straface, E.; Matarrese, P.; Ascione, B.; Coinu, R.; Canu, S.; Galluzzo, P.; Marino, M. and Franconi, F. (2008) Redox state and gender differences in vascular smooth muscle cells. FEBS Lett., 582(5), 635-642.
103. Maselli, A.; Matarrese, P.; Straface, E.; Canu, S.; Franconi, F. and Malorni, W. (2009) Cell sex: a new look at cell fate studies. FASEB J., 23(4), 978-984.
104. Ortona, E.; Margutti, P.; Matarrese, P.; Franconi, F. and Malorni, W. (2008) Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun. Rev., 7(7), 579-584.
105. Pierdominici, M.; Ortona, E.; Franconi, F.; Caprio, M.; Straface, E. and Malorni, W. (2011) Gender specific aspects of cell death in the cardiovascular system. Curr. Pharma Des., 17(11), 1046-1055.
106. Straface, E.; Vona, R.; Gambardella, L.; Ascione, B.; Marino, M.; Bulzomi, P.; Canu, S.; Coinu, R.; Rosano, G.; Malorni, W. and Franconi, F. (2009) Cell sex determines anoikis resistance in vascular smooth muscle cells. FEBS Lett., 583(21), 3448-3454.
107. Hotamisligil, G. S. (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell, 140(6), 900-917.
108. Li, S.; Brown, M. S. and Goldstein, J. L. (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA, 107(8), 3441-3446.
109. Yang, L.; Li, P.; Fu, S.; Calay, E. S. and Hotamisligil, G. S. (2010) Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab., 11(6), 467-478.
110. Liu, H. Y.; Han, J.; Cao, S. Y.; Hong, T.; Zhuo, D.; Shi, J.; Liu, Z. and Cao, W. (2009) Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J. Biol. Chem., 284(45), 31484-31492.
111. Hur, K. Y.; Jung, H. S. and Lee, M. S. (2010) Role of autophagy in beta-cell function and mass. Diabetes Obes. Metab., 12(Suppl 2), 20-26.
112. American Diabetes Association. (2009) Standards of medical care in diabetes-2009. Diabetes Care, 32(1), S13-61.
113. Kim, C.; Newton, K. M. and Knopp, R. H. (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care, 25(10), 1862-1868.
114. Lee, A. J.; Hiscock, R. J.; Wein, P.; Walker, S. P. and Permezel, M. (2007) Gestational diabetes mellitus: clinical predictors and longterm risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care, 30(4), 878-883.
115. Toulis, K. A.; Goulis, D. G.; Kolibianakis, E. M.; Venetis, C. A.; Tarlatzis, B. C. and Papadimas, I. (2009) Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil. Steril., 92(2), 667-677.
116. Apridonidze, T.; Essah, P. A.; Iuorno, M. J. and Nestler, J. E. (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 90(4), 1929-1935.
117. Eisenhardt, S.; Schwarzmann, N.; Henschel, V.; Germeyer, A.; von Wolff, M.; Hamann, A. and Strowitzki, T. (2006) Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab., 91(3), 946-952.
118. Ornoy, A. (2011) Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod. Toxicol., 32(2), 205-212.
119. Buinauskiene, J.; Baliutaviciene, D. and Zalinkevicius, R. (2004) Glucose tolerance of 2-to 5-yr-old offspring of diabetic mothers. Pediatr. Diabetes, 5(3), 143-146.
120. Clausen, T. D.; Mathiesen, E. R.; Hansen, T.; Pedersen, O.; Jensen, D. M.; Lauenborg, J. and Damm, P. (2008) High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care, 31(2), 340-346.
121. Sojo, L.; Garcia-Patterson, A.; Maria, M. A.; Martin, E.; Ubeda, J.; Adelantado, J. M.; de Leiva, A. and Corcoy, R. (2010) Are birth weight predictors in diabetic pregnancy the same in boys and girls? Eur. J. Obstet. Gynecol. Reprod. Biol., 153(1), 32-37.
122. Barrett-Connor, E. L.; Cohn, B. A.; Wingard, D. L. and Edelstein, S. L. (1991) Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA, 265(5), 627-631.
123. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54(6), 1615-1625.
124. Garg, J. P. and Bakris, G. L. (2002) Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc. Med., 7(1), 35-43.
125. Klausen, K.; Borch-Johnsen, K.; Feldt-Rasmussen, B.; Jensen, G.; Clausen, P.; Scharling, H.; Appleyard, M. and Jensen, J. S. (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation, 110(1), 32-35.
126. Veglio, M.; Sivieri, R.; Chinaglia, A.; Scaglione, L. and Cavallo-Perin, P. (2000) QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care, 23(9), 1381-1383.
127. Vinik, A. I.; Maser, R. E.; Mitchell, B. D. and Freeman, R. (2003) Diabetic autonomic neuropathy. Diabetes Care, 26(5), 1553-1579.
128. Witte, D. R.; Tesfaye, S.; Chaturvedi, N.; Eaton, S. E.; Kempler, P. and Fuller, J. H. (2005) Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia, 48(1), 164-171.
129. Tryniszewski, W.; Kusmierczyk, J.; Maziarz, Z.; Gos, R.; Mikhailidis, D. P.; Banach, M.; Rysz, J. and Pesudovs, K. (2011) Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes. J. Diabetes Complications., 25(4), 253-257.
130. Cheung, N.; Tikellis, G. and Wang, J. J. (2007) Diabetic retinopathy. Ophthalmology, 114(11), 2098-2099; author reply 2099.
131. Fishbein, H. and Palumbo, P. J. Acute metabolic complications in diabetes. In National Diabetes Data Group. Diabetes in America, 2nd ed, National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases, Eds. Washington, DC, 1995; pp. 283-291.
132. Faich, G. A.; Fishbein, H. A. and Ellis, S. E. (1983) The epidemiology of diabetic acidosis: a population-based study. Am. J. Epidemiol., 117(5), 551-558.
133. Akalin, S.; Berntorp, K.; Ceriello, A.; Das, A. K.; Kilpatrick, E. S.; Koblik, T.; Munichoodappa, C. S.; Pan, C. Y.; Rosenthall, W.; Shestakova, M.; Wolnik, B.; Woo, V.; Yang, W. Y. and Yilmaz, M. T. (2009) Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int. J. Clin. Pract., 63(10), 1421-1425.
134. Stettler, C.; Allemann, S.; Juni, P.; Cull, C. A.; Holman, R. R.; Egger, M.; Krahenbuhl, S. and Diem, P. (2006) Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Metaanalysis of randomized trials. Am. Heart J., 152(1), 27-38.
135. Skyler, J. S.; Bergenstal, R.; Bonow, R. O.; Buse, J.; Deedwania, P.; Gale, E. A.; Howard, B. V.; Kirkman, M. S.; Kosiborod, M.; Reaven, P. and Sherwin, R. S. (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 32(1), 187-192.
136. Beckman, J. A.; Creager, M. A. and Libby, P. (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 287(19), 2570-2581.
137. Haffner, S. M.; Lehto, S.; Ronnemaa, T.; Pyorala, K. and Laakso, M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med., 339(4), 229-234.
138. Howard, B. V.; Cowan, L. D.; Go, O.; Welty, T. K.; Robbins, D. C. and Lee, E. T. (1998) Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care, 21(8), 1258-1265.
139. Hurst, R. T. and Lee, R. W. (2003) Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann. Intern. Med., 139(10), 824-834.
140. Gu, K.; Cowie, C. C. and Harris, M. I. (1999) Diabetes and decline in heart disease mortality in US adults. JAMA, 281(14), 1291-1297.
141. Hu, F. B.; Stampfer, M. J.; Solomon, C. G.; Liu, S.; Willett, W. C.; Speizer, F. E.; Nathan, D. M. and Manson, J. E. (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch. Intern. Med., 161(14), 1717-1723.
142. Hu, G. (2003) Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia, 46(5), 608-617.
143. Lundberg, V.; Stegmayr, B.; Asplund, K.; Eliasson, M. and Huhtasaari, F. (1997) Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J. Intern. Med., 241(6), 485-492.
144. Barrett-Connor, E. and Ferrara, A. (1998) Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care, 21(8), 1236-1239.
145. Huxley, R.; Barzi, F. and Woodward, M. (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ, 332(7533), 73-78.
146. Donahue, R. P.; Rejman, K.; Rafalson, L. B.; Dmochowski, J.; Stranges, S. and Trevisan, M. (2007) Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study. Diabetes Care, 30(2), 354-359.
147. Orchard, T. J. (1996) The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in noninsulin-dependent diabetes mellitus. Ann. Med., 28(4), 323-333.
148. Schwab, K. O.; Doerfer, J.; Naeke, A.; Rohrer, T.; Wiemann, D.; Marg, W.; Hofer, S. E. and Holl, R. W. (2009) Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes--reference data from the German diabetes documentation and quality management system (DPV). Pediatr. Diabetes, 10(3), 184-192.
149. Soedamah-Muthu, S. S.; Fuller, J. H.; Mulnier, H. E.; Raleigh, V. S.; Lawrenson, R. A. and Colhoun, H. M. (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia, 49(4), 660-666.
150. Schwab, K. O.; Doerfer, J.; Marg, W.; Schober, E. and Holl, R. W. (2010) Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatr Diabetes, 11(5), 357-363.
151. Hu, F. B.; Stampfer, M. J.; Haffner, S. M.; Solomon, C. G.; Willett, W. C. and Manson, J. E. (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care, 25(7), 1129-1134.
152. Haffner, S. M.; Miettinen, H. and Stern, M. P. (1997) Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia, 40(6), 711-717.
153. The Diabetes Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med., 329(14), 977-986.
154. Festa, A.; D'Agostino, R. Jr.; Tracy, R. P. and Haffner, S. M. (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes, 51(4), 1131-1137.
155. Kuller, L. H.; Tracy, R. P.; Shaten, J. and Meilahn, E. N. (1996) Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol., 144(6), 537-547.
156. Meigs, J. B.; Hu, F. B.; Rifai, N. and Manson, J. E. (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA, 291(16), 1978-1986.
157. Ridker, P. M.; Cushman, M.; Stampfer, M. J.; Tracy, R. P. and Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 336(14), 973-979.
158. Schmidt, M. I.; Duncan, B. B.; Sharrett, A. R.; Lindberg, G.; Savage, P. J.; Offenbacher, S.; Azambuja, M. I.; Tracy, R. P. and Heiss, G. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 353(9165), 1649-1652.
159. Steinberg, H. O.; Paradisi, G.; Cronin, J.; Crowde, K.; Hempfling, A.; Hook, G. and Baron, A. D. (2000) Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation, 101(17), 2040-2046.
160. Ossei-Gerning, N.; Wilson, I. J. and Grant, P. J. (1998) Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb. Haemost., 79 (4), 736-740.
161. Chan, P. and Pan, W. H. (1995) Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients. Diabet. Med., 12(6), 504-507.
162. Knowler, W. C.; Barrett-Connor, E.; Fowler, S. E.; Hamman, R. F.; Lachin, J. M.; Walker, E. A. and Nathan, D. M. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 346(6), 393-403.
163. Tuomilehto, J.; Lindstrom, J.; Eriksson, J. G.; Valle, T. T.; Hamalainen, H.; Ilanne-Parikka, P.; Keinanen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Rastas, M.; Salminen, V. and Uusitupa, M. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med., 344(18), 1343-1350.
164. Barrett-Connor, E.; Giardina, E. G.; Gitt, A. K.; Gudat, U.; Steinberg, H. O. and Tschoepe, D. (2004) Women and heart disease: the role of diabetes and hyperglycemia. Arch. Intern. Med., 164(9), 934-942.
165. Dallongevillle, J.; De Bacquer, D.; Heidrich, J.; De Backer, G.; Prugger, C.; Kotseva, K.; Montaye, M. and Amouyel, P. (2010) Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart, 96(21), 1744-1749.
166. Juutilainen, A.; Kortelainen, S.; Lehto, S.; Ronnemaa, T.; Pyorala, K. and Laakso, M. (2004) Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care, 27(12), 2898-2904.
167. Miller, M. E.; Bonds, D. E.; Gerstein, H. C.; Seaquist, E. R.; Bergenstal, R. M.; Calles-Escandon, J.; Childress, R. D.; Craven, T. E.; Cuddihy, R. M.; Dailey, G.; Feinglos, M. N.; Ismail-Beigi, F.; Largay, J. F.; O'Connor, P. J.; Paul, T.; Savage, P. J.; Schubart, U. K.; Sood, A. and Genuth, S. (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ, 340, b5444.
168. Cavalot, F.; Petrelli, A.; Traversa, M.; Bonomo, K.; Fiora, E.; Conti, M.; Anfossi, G.; Costa, G. and Trovati, M. (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J. Clin. Endocrinol. Metab., 91(3), 813-819.
169. Paynter, N. P.; Mazer, N. A.; Pradhan, A. D.; Gaziano, J. M.; Ridker, P. M. and Cook, N. R. (2011) Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent. Arch. Intern. Med., 171(19), 1712-1718.
170. Faerch, K.; Borch-Johnsen, K.; Vaag, A.; Jørgensen, T. and Witte, D. R. (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia, 53, 858-865.
171. Kothari, V.; Stevens, R. J.; Adler, A. I.; Stratton, I. M.; Manley, S. E.; Neil, H. A. and Holman, R. R. (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke, 33(7), 1776-1781.
172. Lin, M.; Chen, Y. and Sigal, R. J. (2007) Stroke associated with diabetes among Canadians: sex and age differences. Neuroepidemiology, 28(1), 46-49.
173. Mulnier, H. E.; Seaman, H. E.; Raleigh, V. S.; Soedamah-Muthu, S. S.; Colhoun, H. M.; Lawrenson, R. A. and De Vries, C. S. (2006) Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia, 49(12), 2859-2865.
174. Arboix, A.; Milian, M.; Oliveres, M.; Garcia-Eroles, L. and Massons, J. (2006) Impact of female gender on prognosis in type 2 diabetic patients with ischemic stroke. Eur. Neurol., 56(1), 6-12.
175. Sundquist, K. and Li, X. (2006) Type 1 diabetes as a risk factor for stroke in men and women aged 15-49: a nationwide study from Sweden. Diabet. Med., 23(11), 1261-1267.
176. Maisch, B.; Alter, P. and Pankuweit, S. (2011) Diabetic cardiomyopathy-fact or fiction? Herz., 36 (2), 102-115.
177. Ren, J. and Ceylan-Isik, A. F. (2004) Diabetic cardiomyopathy: do women differ from men? Endocrine, 25(2), 73-83.
178. Regitz-Zagrosek, V.; Petrov, G.; Lehmkuhl, E.; Smits, J. M.; Babitsch, B.; Brunhuber, C.; Jurmann, B.; Stein, J.; Schubert, C.; Merz, N. B.; Lehmkuhl, H. B. and Hetzer, R. (2010) Heart transplantation in women with dilated cardiomyopathy. Transplantation, 89(2), 236-244.
179. Holscher, C. (2011) Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Biochem. Soc. Trans., 39(4), 891-897.
180. Vinik, A. I.; Holland, M. T.; Le Beau, J. M.; Liuzzi, F. J.; Stansberry, K. B. and Colen, L. B. (1992) Diabetic neuropathies. Diabetes Care, 15(12), 1926-1975.
181. Albers, J. W.; Brown, M. B.; Sima, A. A. and Greene, D. A. (1996) Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology, 46(1), 85-91.
182. Booya, F.; Bandarian, F.; Larijani, B.; Pajouhi, M.; Nooraei, M. and Lotfi, J. (2005) Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol., 5, 24.
183. Brown, M. J.; Bird, S. J.; Watling, S.; Kaleta, H.; Hayes, L.; Eckert, S. and Foyt, H. L. (2004) Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care, 27(5), 1153-1159.
184. Dyck, P. J.; Litchy, W. J.; Lehman, K. A.; Hokanson, J. L.; Low, P. A. and O'Brien, P. C. (1995) Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology, 45(6), 1115-1121.
185. Pop-Busui, R.; Lu, J.; Lopes, N. and Jones, T. L. (2009) Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J. Peripher. Nerv. Syst., 14(1), 1-13.
186. Mayfield, J. A.; Reiber, G. E.; Nelson, R. G. and Greene, T. (1996) A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care, 19(7), 704-709.
187. Aaberg, M. L.; Burch, D. M.; Hud, Z. R. and Zacharias, M. P. (2008) Gender differences in the onset of diabetic neuropathy. J. Diabetes Complications, 22(2), 83-87.
188. Peek, M. E. (2010) Gender Differences in Diabetes-related Lower Extremity Amputations. Clin. Orthop. Relat. Res., 469(7), 1951-1955.
189. Prompers, L.; Schaper, N.; Apelqvist, J.; Edmonds, M.; Jude, E.; Mauricio, D.; Uccioli, L.; Urbancic, V.; Bakker, K.; Holstein, P.; Jirkovska, A.; Piaggesi, A.; Ragnarson-Tennvall, G.; Reike, H.; Spraul, M.; Van Acker, K.; Van Baal, J.; Van Merode, F.; Ferreira, I. and Huijberts, M. (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia, 51(5), 747-755.
190. Liu, Z.; Fu, C.; Wang, W. and Xu, B. (2010) Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a crosssectional hospital based survey in urban China. Health Qual. Life Outcomes, 8, 62.
191. Seale, J. P.; Davis-Smith, M. and Okosun, I. (2006) Ethnic and gender differences in lifestyle risk factors in a bi-ethnic primary care sample: prevalence and clinical implications. Ethn. Dis., 16(2), 460-467.
192. Gu, H. F.; Alvarsson, A.; Efendic, S. and Brismar, K. (2009) SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study. Gend. Med., 6(4), 555-564.
193. Gonzalez, J. S.; Safren, S. A.; Cagliero, E.; Wexler, D. J.; Delahanty, L.; Wittenberg, E.; Blais, M. A.; Meigs, J. B. and Grant, R. W. (2007) Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care, 30(9), 2222-2227.
194. Maser, R. E. and Lenhard, M. J. (2005) Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J. Clin. Endocrinol. Metab., 90(10), 5896-5903.
195. Griffin, M.; Lee, H. W.; Zhao, L. and Eghbali-Webb, M. (2000) Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia: effects of estrogen. Mol. Cell Biochem., 215(1-2), 21-30.
196. Kadokami, T.; McTiernan, C. F.; Kubota, T.; Frye, C. S. and Feldman, A. M. (2000) Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J. Clin. Invest., 106(4), 589-597.
197. Peng, S.; Yu, Y.; Hao, K.; Xing, H.; Li, D.; Chen, C.; Huang, A.; Hong, X.; Feng, Y.; Zhang, Y.; Li, J.; Wang, B.; Wu, D.; Wang, X. and Xu, X. (2006) Heart rate-corrected QT interval duration is significantly associated with blood pressure in Chinese hypertensives. J. Electrocardiol., 39(2), 206-210.
198. Schouten, E. G.; Dekker, J. M.; Meppelink, P.; Kok, F. J.; Vandenbroucke, J. P. and Pool, J. (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation, 84(4), 1516-1523.
199. Dekker, J. M.; Crow, R. S.; Hannan, P. J.; Schouten, E. G. and Folsom, A. R. (2004) Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middleaged men and women: the ARIC study. J. Am. Coll Cardiol., 43(4), 565-571.
200. Okin, P. M.; Devereux, R. B.; Lee, E. T.; Galloway, J. M. and Howard, B. V. (2004) Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes, 53(2), 434-440.
201. Veglio, M.; Borra, M.; Stevens, L. K.; Fuller, J. H. and Perin, P. C. (1999) The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia, 42(1), 68-75.
202. Veglio, M.; Bruno, G.; Borra, M.; Macchia, G.; Bargero, G.; D'Errico, N.; Pagano, G. F. and Cavallo-Perin, P. (2002) Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J. Intern. Med., 251(4), 317-324.
203. Veglio, M.; Giunti, S.; Stevens, L. K.; Fuller, J. H. and Perin, P. C. (2002) Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia: the EURODIAB IDDM Complications Study Group. Diabetes Care, 25(4), 702-707.
204. Rana, B. S.; Lim, P. O.; Naas, A. A.; Ogston, S. A.; Newton, R. W.; Jung, R. T.; Morris, A. D. and Struthers, A. D. (2005) QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart, 91(1), 44-50.
205. Akhtar, M. (1990) Clinical spectrum of ventricular tachycardia. Circulation, 82(5), 1561-1573.
206. Vlay, S. C.; Mallis, G. I.; Brown, E. J. Jr. and Cohn, P. F. (1984) Documented sudden cardiac death in prolonged QT syndrome. Arch. Intern. Med., 144(4), 833-835.
207. Giunti, S.; Bruno, G.; Lillaz, E.; Gruden, G.; Lolli, V.; Chaturvedi, N.; Fuller, J. H.; Veglio, M. and Cavallo-Perin, P. (2007) Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care, 30(8), 2057-2063.
208. Whitsel, E. A.; Boyko, E. J. and Siscovick, D. S. (2000) Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care, 23(2), 241-247.
209. Zoungas, S.; Patel, A.; Chalmers, J.; de Galan, B. E.; Li, Q.; Billot, L.; Woodward, M.; Ninomiya, T.; Neal, B.; MacMahon, S.; Grobbee, D. E.; Kengne, A. P.; Marre, M. and Heller, S. (2010) Severe hypoglycemia and risks of vascular events and death. N. Engl. J. Med., 363(15), 1410-1418.
210. Nosadini, R. and Tonolo, G. (2011) Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr. Metab. Cardiovasc. Dis., 21(2), 79-85.
211. Seliger, S. L.; Davis, C. and Stehman-Breen, C. (2001) Gender and the progression of renal disease. Curr. Opin. Nephrol. Hypertens., 10(2), 219-225.
212. Schultz, C. J.; Konopelska-Bahu, T.; Dalton, R. N.; Carroll, T. A.; Stratton, I.; Gale, E. A.; Neil, A. and Dunger, D. B. (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care, 22(3), 495-502.
213. Maric, C. (2009) Sex, diabetes and the kidney. Am. J. Physiol. Renal. Physiol., 296(4), F680-688.
214. Maric, C. and Hall, J. E. (2011) Obesity, metabolic syndrome and diabetic nephropathy. Contrib. Nephrol., 170, 28-35.
215. Hajjar, I. and Kotchen, T. A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290(2), 199-206.
216. Thoenes, M.; Neuberger, H. R.; Volpe, M.; Khan, B. V.; Kirch, W. and Bohm, M. (2010) Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J. Hum. Hypertens., 24(5), 336-344.
217. Sibley, S. D.; Thomas, W.; de Boer, I.; Brunzell, J. D. and Steffes, M. W. (2006) Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am. J. Kidney Dis., 47(2), 223-232.
218. Gnudi, L. and Goldsmith, D. (2010) Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes. F1000 Med. Rep., 2,. pii: 18.
219. Cherney, D. Z.; Sochett, E. B. and Miller, J. A. (2005) Gender differences in renal responses to hyperglycemia and angiotensinconverting enzyme inhibition in diabetes. Kidney Int., 68(4), 1722-1728.
220. Molitch, M. E.; DeFronzo, R. A.; Franz, M. J.; Keane, W. F.; Mogensen, C. E.; Parving, H. H. and Steffes, M. W. (2004) Nephropathy in diabetes. Diabetes Care, 27(Suppl 1), S79-83.
221. Niskanen, L.; Laaksonen, D. E.; Lindstrom, J.; Eriksson, J. G.; Keinanen-Kiukaanniemi, S.; Ilanne-Parikka, P.; Aunola, S.; Hamalainen, H.; Tuomilehto, J. and Uusitupa, M. (2006) Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care, 29(3), 709-711.
222. Choi, H. K. and Ford, E. S. (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford), 47(5), 713-717.
223. Obermayr, R. P.; Temml, C.; Gutjahr, G.; Knechtelsdorfer, M.; Oberbauer, R. and Klauser-Braun, R. (2008) Elevated uric acid increases the risk for kidney disease. J. Am. Soc. Nephrol., 19(12), 2407-2413.
224. Zhang, X.; Saaddine, J. B.; Chou, C. F.; Cotch, M. F.; Cheng, Y. J.; Geiss, L. S.; Gregg, E. W.; Albright, A. L.; Klein, B. E. and Klein, R. (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA, 304(6), 649-656.
225. Kashani, A. H.; Zimmer-Galler, I. E.; Shah, S. M.; Dustin, L.; Do, D. V.; Eliott, D.; Haller, J. A. and Nguyen, Q. D. (2010) Retinal thickness analysis by race, gender, and age using Stratus OCT. Am. J. Ophthalmol., 149(3), 496-502 e491.
226. Pradeepa, R.; Anitha, B.; Mohan, V.; Ganesan, A. and Rema, M. (2008) Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet. Med., 25(5), 536-542.
227. Rani, P. K.; Raman, R.; Chandrakantan, A.; Pal, S. S.; Perumal, G. M. and Sharma, T. (2009) Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J. Postgrad. Med., 55(2), 92-96.
228. Deshpande, A. D.; Harris-Hayes, M. and Schootman, M. (2008) Epidemiology of diabetes and diabetes-related complications. Phys. Ther., 88(11), 1254-1264.
229. Saydah, S. H.; Fradkin, J. and Cowie, C. C. (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA, 291(3), 335-342.
230. Correa-de-Araujo, R.; McDermott, K. and Moy, E. (2006) Gender differences across racial and ethnic groups in the quality of care for diabetes. Womens Health Issues, 16(2), 56-65.
231. AHRQ. National Healthcare Disparities Report. Agency for Healthcare Research and Quality: Rockville, 2004.
232. Cowie, C. C.; Port, F. K.; Wolfe, R. A.; Savage, P. J.; Moll, P. P. and Hawthorne, V. M. (1989) Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N. Engl. J. Med., 321(16), 1074-1079.
233. Karter, A. J.; Ferrara, A.; Liu, J. Y.; Moffet, H. H.; Ackerson, L. M. and Selby, J. V. (2002) Ethnic disparities in diabetic complications in an insured population. JAMA, 287(19), 2519-2527.
234. Lavery, L. A.; van Houtum, W. H.; Ashry, H. R.; Armstrong, D. G. and Pugh, J. A. (1999) Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med. J., 92(6), 593-599.
235. Rostand, S. G.; Kirk, K. A.; Rutsky, E. A. and Pate, B. A. (1982) Racial differences in the incidence of treatment for end-stage renal disease. N. Engl. J. Med., 306(21), 1276-1279.
236. Trivedi, A. N.; Zaslavsky, A. M.; Schneider, E. C. and Ayanian, J. Z. (2005) Trends in the quality of care and racial disparities in Medicare managed care. N. Engl. J. Med., 353(7), 692-700.
237. Jarvie, J. L. and Foody, J. M. (2010) Recognizing and improving health care disparities in the prevention of cardiovascular disease in women. Curr. Cardiol. Rep., 12(6), 488-496.
238. Braunwald, E.; Domanski, M. J.; Fowler, S. E.; Geller, N. L.; Gersh, B. J.; Hsia, J.; Pfeffer, M. A.; Rice, M. M.; Rosenberg, Y. D. and Rouleau, J. L. (2004) Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N. Engl. J. Med., 351(20), 2058-2068.
239. Freeman, D. J.; Norrie, J.; Sattar, N.; Neely, R. D.; Cobbe, S. M.; Ford, I.; Isles, C.; Lorimer, A. R.; Macfarlane, P. W.; McKillop, J. H.; Packard, C. J.; Shepherd, J. and Gaw, A. (2001) Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation, 103(3), 357-362.
240. Gerstein, H. C.; Swedberg, K.; Carlsson, J.; McMurray, J. J.; Michelson, E. L.; Olofsson, B.; Pfeffer, M. A. and Yusuf, S. (2008) The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch. Intern. Med., 168(15), 1699-1704.
241. Karlsson, J.; Taft, C.; Sjostrom, L.; Torgerson, J. S. and Sullivan, M. (2003) Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale. Int. J. Obes. Relat. Metab. Disord., 27(5), 617-630.
242. Lithell, H.; Hansson, L.; Skoog, I.; Elmfeldt, D.; Hofman, A.; Olofsson, B.; Trenkwalder, P. and Zanchetti, A. (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J. Hypertens., 21(5), 875-886.
243. Torgerson, J. S.; Hauptman, J.; Boldrin, M. N. and Sjostrom, L. (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161.
244. Trenkwalder, P.; Elmfeldt, D.; Hofman, A.; Lithell, H.; Olofsson, B.; Papademetriou, V.; Skoog, I. and Zanchetti, A. (2005) The Study on COgnition and Prognosis in the Elderly (SCOPE)-major CV events and stroke in subgroups of patients. Blood Press, 14(1), 31-37.
245. Yusuf, S.; Ostergren, J. B.; Gerstein, H. C.; Pfeffer, M. A.; Swedberg, K.; Granger, C. B.; Olofsson, B.; Probstfield, J. and McMurray, J. V. (2005) Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation, 112(1), 48-53.
246. Yusuf, S.; Sleight, P.; Pogue, J.; Bosch, J.; Davies, R. and Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med., 342(3), 145-153.
247. Lewis, E. J.; Hunsicker, L. G. and Rodby, R. A. (2001) A clinical trial in type 2 diabetic nephropathy. Am. J. Kidney Dis., 38(4 Suppl 1), S191-194.
248. Franconi, F.; Carru, C.; Malorni, W.; Vella, S. and Mercuro, G. (2011) The effect of sex/gender on cardiovascular pharmacology. Curr. Pharm. Des., 17(11), 1095-1107.
249. Franconi, F.; Carru, C.; Malorni, W.; Vella, S. and Mercuro, G. (2011) The effect of gender on cardiovascular pharmacology. Curr. Pharm. Design., 17(11), 1095-1107.
250. Hibbard, J. H. and Pope, C. R. (1983) Gender roles, illness orientation and use of medical services. Soc. Sci. Med., 17(3), 129-137.
251. Russell-Jones, D. and Khan, R. (2007) Insulin-associated weight gain in diabetes--causes, effects and coping strategies. Diabetes Obes. Metab., 9(6), 799-812.
252. Carver, C. (2006) Insulin treatment and the problem of weight gain in type 2 diabetes. Diabetes Educ., 32(6), 910-917.
253. Polonsky, W. H.; Fisher, L.; Guzman, S.; Villa-Caballero, L. and Edelman, S. V. (2005) Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care, 28(10), 2543-2545.
254. Nam, S.; Chesla, C.; Stotts, N. A.; Kroon, L. and Janson, S. L. (2010) Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care, 33(8), 1747-1749.
255. Gregg, E. W.; Gu, Q.; Cheng, Y. J.; Narayan, K. M. and Cowie, C. C. (2007) Mortality trends in men and women with diabetes, 1971 to 2000. Ann. Intern. Med., 147(3), 149-155.
256. Roglic, G. and Unwin, N. (2010) Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res. Clin. Pract., 87(1), 15-19.